Agenus Thanks ESMO and Ben Schlechter for Sharing the New Data of BOT/BAL in Refractory MSS CRC Agenus shared on LinkedIn: “Thank you to ESMO – European Society for Medical Oncology-GI and Dr. Ben Schlechter of Dana-Farber Cancer Institute for sharing the new data of BOT/BAL in refractory MSS colorectal cancer.” More posts about ESMOGI25. Blog Posts Agenus Ben Schlechter cancer colorectal cancer CRC ESMO-GI OncoDaily Oncology
